The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial



Sargeant, Jack A, King, James A, Yates, Thomas, Redman, Emma L, Bodicoat, Danielle H, Chatterjee, Sudesna, Edwardson, Charlotte L, Gray, Laura J, Poulin, Benoit, Waheed, Ghazala
et al (show 7 more authors) (2022) The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial. DIABETES OBESITY & METABOLISM.

[img] Text
DOM-22-0060-OP R1_Sargeant et al.docx - Accepted Version

Download (851kB)
Item Type: Article
Uncontrolled Keywords: compensation, energy balance, energy restriction, gut hormones, SGLT2 inhibitors
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 10 Jun 2022 07:29
Last Modified: 19 Aug 2022 00:11
DOI: 10.1111/dom.14721
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3156108